This review aims to summarize the available evidence on this topic
Companies should identify the most influential stakeholders for their brand whether HCPs, influencers and / or digital platforms and build partnerships that enable scalable awareness and adherence
Under the Medicare GLP-1 Bridge, eligible beneficiaries can get Medicare coverage of GLP-1s for obesity for a $50 monthly copayment, which will not count towards the Part D deductible or out-of-pocket spending cap and Part D Low-Income Subsidy cost-sharing assistance will not apply
While these liver enzyme level increases were generally without symptoms, healthcare providers must monitor liver function tests in individuals receiving retatrutide
Step 3 Dose Titration: Retatrutide is initiated at a low starting dose and titrated gradually over several weeks to minimize gastrointestinal side effects
The SURPASS-2 trial showing tirzepatide achieving significantly greater HbA1c reduction and weight loss than semaglutide in T2DM patients, and the SURMOUNT trials showing up to 22% average body weight reduction in obese patients, have established tirzepatide as the clinical performance leader in the class